返回 
加入收藏
我国制售假药的现状、特点及其监管对策研究
x
请在关注微信后，向客服人员索取文件
| 篇名： | 我国制售假药的现状、特点及其监管对策研究 |
| TITLE： | |
| 摘要： | 目的：探讨我国制售假药的现状、特点及其监管对策。方法：以我国公安机关2011－2015年侦办的7 500余起假药案件为基础，选择其中50起涉案假药数量大、金额高、人数多、地域广和社会影响较大的典型案件的相关数据进行分析，并提出监管对策。结果与结论：我国假药案件和涉案人数整体上呈快速增长态势，分别从2011年的近500起、900人增长到2015年的近2 500起、6 000人。50起典型案件中，涉案假药种类多集中于治疗性功能障碍药（占23.8％）、美容药和减肥药（占19.6％）、止咳平喘药（占14.2％）、治疗风湿骨病药（占13.9％）、抗糖尿病药（占7.3％）、抗肿瘤药（占6.6％）等；网络销售假药有42起（占84％）；无证生产销售假药有46起（占92％）；非法代购假药有3起（占6％）。整体来看，我国制售假药具有涉案金额高、违法犯罪活动隐蔽、受害者多为低收入人群等特点。建议加强假药监管工作，创新监管方式；加强药品监管部门与公安机关联合执法，顺畅行政执法与刑事司法；创新情报信息运行体制机制，建立信息共享平台与信息通报机制；强化互联网监测，加强与制药企业合作；加强舆论宣传，震慑犯罪分子等。 |
| ABSTRACT： | OBJECTIVE： To investigate the status quo and characteristics of manufacturing and selling counterfeit drugs in China， and to explore supervision strategies. METHODS： Among 7 500 counterfeit drugs cases investigated by public security organization during 2011-2015， 50 typical cases， which involved large amount of counterfeit drugs， large sum of money， a large number of people， a broad geographic area and huge social consequences， were selected and analyzed to put forward supervision strategies. RESULTS & CONCLUSIONS： Both the case number of counterfeit drug and the people involved were increasing rapidly in China， increasing from 500 cases and 900 persons in 2011 to 2 500 cases and 6 000 persons in 2015. Among 50 typical cases， involved counterfeit drugs mostly focused on sexual dysfunction drugs （23.8％）， cosmetic drugs and weight loss drugs （19.6％）， antitussive and antiasthmatic drugs （14.2％）， anti-rheumatism drugs （13.9％）， antidiabetic drugs （7.3％） and antitumor drugs （6.6％）， etc. There were 42 cases of online counterfeit drugs sales （84％）， 46 cases of counterfeit drugs production and sales activities without a license （92％） and 3 cases of illegal counterfeit drugs purchase service （6％）. On the whole， manufacturing and selling counterfeit drugs activity in China has the following features， such as large sum of money is involved； criminal activities are very covert； most victims are low-income workers. It is suggested to strengthen the supervision work and innovative approach； enhance the joint law enforcement of drug administration and public security organs，and promote connection between administrative law enforcement and criminal justice of drug cases； innovate information operation system and mechanism， and establish information sharing platform and reporting system； strengthen the monitoring of internet and cooperation with pharmaceutical companies； improve the publicity and deter criminals. |
| 期刊： | 2016年第27卷第28期 |
| 作者： | 周志刚，王祎，王嘉玲 |
| AUTHORS： | ZHOU Zhigang，WANG Yi，WANG Jialing |
| 关键字： | 假药；现状；监管对策；研究 |
| KEYWORDS： | Counterfeit drugs； Status quo； Supervision strategy； Research |
| 阅读数： | 636 次 |
| 本月下载数： | 17 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
